These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 724771)

  • 21. [Comparative evaluation of the methods for isolating cordanum from biological matter].
    Vol'gram EN
    Sud Med Ekspert; 1987; 30(2):34-8. PubMed ID: 3617134
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the pharmacokinetics of talinolol, a new beta 1-receptor blocking agent.
    Haustein KO; Fritzsche K
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):392-5. PubMed ID: 6117520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Negative inotropic reflex effects in the dog ventricle before and after beta-receptor blockade].
    Scheufler K; Opitz H
    Biomed Biochim Acta; 1986; 45(5):637-47. PubMed ID: 2875715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of talinolol from laminated polyacrylic films.
    Dittgen M; Adam H; Strobel A
    Pharmazie; 1990 Oct; 45(10):797-8. PubMed ID: 2089399
    [No Abstract]   [Full Text] [Related]  

  • 27. [The use of Cordanum in combination with Corinfar-Retard for the treatment of ectopic arrhythmias in the sick sinus syndrome in patients with ischemic heart disease].
    Doshchitsin VL; Martynova VN; Lindo IN; Kuchinskaia NG; Chernova EV; Shatukhina EIu; Arsent'eva NR
    Ter Arkh; 1997; 69(9):59-61. PubMed ID: 9411831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metoprolol overdose.
    Shore ET; Cepin D; Davidson MJ
    Ann Emerg Med; 1981 Oct; 10(10):524-7. PubMed ID: 7283217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metoprolol intoxication.
    Sire S
    Lancet; 1976 Nov; 2(7995):1137. PubMed ID: 62972
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atenolol self-poisoning.
    Shanahan FL; Counihan TB
    Br Med J; 1978 Sep; 2(6139):773. PubMed ID: 698720
    [No Abstract]   [Full Text] [Related]  

  • 32. [Extrelut column extraction for screening of drugs in biological materials by gas chromatography and gas chromatography-mass spectrometry--a fatal poisoning by ingestion of a drug containing acetaminophen, ethenzamide and bromvalerylurea].
    Okamoto I; Chikasue F; Miyazaki T; Yashiki M; Kojima T
    Nihon Hoigaku Zasshi; 1985 Oct; 39(5):386-91. PubMed ID: 4087527
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers.
    Fan L; Mao XQ; Tao GY; Wang G; Jiang F; Chen Y; Li Q; Zhang W; Lei HP; Hu DL; Huang YF; Wang D; Zhou HH
    Xenobiotica; 2009 Mar; 39(3):249-54. PubMed ID: 19280523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.
    Han Y; Guo D; Chen Y; Tan ZR; Zhou HH
    Xenobiotica; 2009 Sep; 39(9):694-9. PubMed ID: 19555315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
    Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
    Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans.
    Gramatté T; Oertel R; Terhaag B; Kirch W
    Clin Pharmacol Ther; 1996 May; 59(5):541-9. PubMed ID: 8646825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardioselective beta receptor blockade in acute myocardial infarct with talinolol].
    Assmann I; Fiehring H; Oltmanns G; Kulick B; Kretzschmar E
    Z Gesamte Inn Med; 1981 Sep; 36(18):637-44. PubMed ID: 6118980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of cordanum and propranolol on coronary resistance].
    Tverskaia MS; Kositskiĭ GI
    Biull Eksp Biol Med; 1988 Jun; 105(6):690-2. PubMed ID: 2898952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
    Siegmund W; Ludwig K; Giessmann T; Dazert P; Schroeder E; Sperker B; Warzok R; Kroemer HK; Cascorbi I
    Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil.
    Gramatté T; Oertel R
    Clin Pharmacol Ther; 1999 Sep; 66(3):239-45. PubMed ID: 10511059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.